Urofollitropin is a medication used in fertility treatments to stimulate
the ovaries to produce eggs. Here is everything you need to know about
urofollitropin and its use:
Urofollitropin is indicated for use in women who are unable to ovulate or
ovulate irregularly. It is also used in women who are undergoing assisted
reproductive technology (ART) treatments, such as in vitro fertilization (IVF)
or intracytoplasmic sperm injection (ICSI).
Urofollitropin is usually administered by injection, with the dosage and
duration of treatment determined by the patient's individual needs. It is
typically started on day 2 or 3 of the menstrual cycle and continued for up to
During treatment with urofollitropin, the patient may need to undergo
frequent monitoring, including ultrasounds and blood tests, to assess follicular
development and hormone levels.
Urofollitropin may cause side effects such as abdominal discomfort,
bloating, headaches, mood changes, and fatigue. In rare cases, it may cause more
serious side effects such as ovarian hyperstimulation syndrome (OHSS), which can
cause abdominal pain, nausea, vomiting, and shortness of breath.
Urofollitropin is contraindicated in women who have known ovarian cysts or
tumors, uncontrolled thyroid or adrenal gland disorders, abnormal bleeding from
the uterus, or pregnancy. It should also not be used by women with a history of
blood clots or stroke.
Women who are undergoing treatment with urofollitropin should be closely
monitored for signs of OHSS or other serious side effects. It is also important
to avoid sexual intercourse during treatment to avoid the risk of multiple
Interactions with other medications
Urofollitropin may interact with other medications, including hormonal
contraceptives, thyroid medications, and glucocorticoids.
In conclusion, urofollitropin is a medication used to stimulate ovulation
in women with infertility issues. It is typically administered by injection and
requires close monitoring for potential side effects. Women who are considering
treatment with urofollitropin should speak with their healthcare provider to
determine if it is the right treatment for their individual needs.